William Blair cut shares of Imperva Inc (NYSE:IMPV) from an outperform rating to a market perform rating in a research note published on Tuesday morning, Marketbeat reports.
Several other analysts have also recently weighed in on the stock. Wells Fargo & Company cut shares of Imperva from an outperform rating to a market perform rating in a report on Monday. Zacks Investment Research cut shares of Imperva from a strong-buy rating to a hold rating in a report on Wednesday, September 27th. BidaskClub upgraded shares of Imperva from a sell rating to a hold rating in a report on Tuesday, September 12th. Piper Jaffray Companies set a $58.00 price target on shares of Imperva and gave the company a buy rating in a report on Monday, August 28th. Finally, Evercore ISI set a $56.00 price target on shares of Imperva and gave the company a buy rating in a report on Thursday, August 10th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. Imperva presently has an average rating of Hold and a consensus target price of $52.34.
Imperva (NYSE:IMPV) last issued its earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.15). Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm had revenue of $74.44 million during the quarter, compared to the consensus estimate of $74.30 million. During the same quarter in the prior year, the business posted ($0.23) EPS. The firm’s revenue for the quarter was up 28.6% on a year-over-year basis.
In other news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the transaction, the director now owns 99,598 shares of the company’s stock, valued at approximately $4,341,476.82. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 2.20% of the stock is owned by insiders.
Several institutional investors and hedge funds have recently bought and sold shares of IMPV. Ameritas Investment Partners Inc. purchased a new position in shares of Imperva in the 1st quarter worth about $102,000. KCG Holdings Inc. purchased a new position in shares of Imperva in the 1st quarter worth about $201,000. Migdal Insurance & Financial Holdings Ltd. raised its position in shares of Imperva by 26.2% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock worth $201,000 after purchasing an additional 866 shares during the last quarter. Amalgamated Bank purchased a new position in shares of Imperva in the 2nd quarter worth about $206,000. Finally, US Bancorp DE raised its position in shares of Imperva by 142.3% in the 1st quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock worth $221,000 after purchasing an additional 3,163 shares during the last quarter. 92.72% of the stock is owned by hedge funds and other institutional investors.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.